Cargando…

Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik

These guidelines constitute an update of the previous “Recommendations on the management of irritable bowel syndrome” issued in 2008. They have been developed by a Task Force organized by the Governing Board of the Polish Society of Gastroenterology. They discuss, with particular emphasis on new sci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pietrzak, Anna, Skrzydło-Radomańska, Barbara, Mulak, Agata, Lipiński, Michał, Małecka-Panas, Ewa, Reguła, Jarosław, Rydzewska, Grażyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Special Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300851/ https://www.ncbi.nlm.nih.gov/pubmed/30581501 http://dx.doi.org/10.5114/pg.2018.78343

Ejemplares similares

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)

Diagnostic and therapeutic recommendations on Helicobacter pylori infection. Recommendations of the Working Group of the Polish Society of Gastroenterology
por: Jaroń, Krzysztof, et al.
Publicado: (2023)

Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club
por: Kadaj-Lipka, Roland, et al.
Publicado: (2018)

Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations
por: Kaniewska, Magdalena, et al.
Publicado: (2014)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Theory and applications of ordered fuzzy numbers: a tribute to professor Witold Kosiński
por: Prokopowicz, Piotr, et al.
Publicado: (2017)

Quality of life and depression in patients with irritable bowel syndrome
por: Kopczyńska, Magdalena, et al.
Publicado: (2018)

New pharmaceuticals in inflammatory bowel disease
por: Łodyga, Michał, et al.
Publicado: (2015)

Probiotics in irritable bowel syndrome – is the quest for the right strain over? Rapid review of existing guidelines and recommendations
por: Marlicz, Wojciech, et al.
Publicado: (2021)

The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes
por: Domżał-Magrowska, Danuta, et al.
Publicado: (2016)

Stress-Related Alterations of Visceral Sensation: Animal Models for Irritable Bowel Syndrome Study
por: Larauche, Muriel, et al.
Publicado: (2011)

The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2021)

Guidelines for Clostridium difficile infection in adults
por: Kukla, Michał, et al.
Publicado: (2020)

Management of acute pancreatitis (AP) – Polish Pancreatic Club recommendations
por: Rosołowski, Mariusz, et al.
Publicado: (2016)

Witold Gombrowicz et le monde de sa jeunesse /
por: Kępiński, Tadeusz
Publicado: (1974)

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2021)

Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
por: Łodyga, Michał, et al.
Publicado: (2021)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

Inflammatory fibroid polyp in the antrum co-occurring with adenomatous polyp in the ascending colon
por: Wronecki, Jakub, et al.
Publicado: (2018)

The Occurrence of Gluten-Related Antibodies, Sensitization to Selected Food Allergens, and Antibodies against Intrinsic Factor in Adult Patients with Diarrhea-Predominant Irritable Bowel Syndrome
por: Bierła, Joanna B., et al.
Publicado: (2023)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
por: Eder, Piotr, et al.
Publicado: (2023)

Dexlansoprazole – a new-generation proton pump inhibitor
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2015)

How to Recognize and Treat Small Intestinal Bacterial Overgrowth?
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2022)

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2020)

Use of functional magnetic resonance imaging in patients with irritable bowel syndrome and functional dyspepsia
por: Skrobisz, Katarzyna, et al.
Publicado: (2019)

Serotonin-Related Gene Variants in Patients with Irritable Bowel Syndrome and Depressive or Anxiety Disorders
por: Grzesiak, Magdalena, et al.
Publicado: (2017)

The incidence of adult type hypolactasia in patients with irritable bowel syndrome
por: Domżał-Magrowska, Danuta, et al.
Publicado: (2023)

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2023)

Determinants of Sleep Quality in Inflammatory Bowel Diseases
por: Sochal, Marcin, et al.
Publicado: (2020)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

Leukocytapheresis in patients with inflammatory bowel diseases
por: Woźniak, Małgorzata, et al.
Publicado: (2021)

Antispasmodics in irritable bowel syndrome – a hoary old chestnut?
por: Pietrzak, Anna
Publicado: (2021)

The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease
por: Woźniak, Małgorzata, et al.
Publicado: (2019)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Butyric acid in irritable bowel syndrome
por: Załęski, Andrzej, et al.
Publicado: (2013)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

Immature granulocytes predict severe acute pancreatitis independently of systemic inflammatory response syndrome
por: Lipiński, Michał, et al.
Publicado: (2017)

Acute pancreatitis and the weekend effect: does weekend admission affect patient outcome?
por: Lipiński, Michał, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ss21cbe9ass94gpm3gmsmb6kb3